Available ablation energies to treat cT1 renal cell cancer: emerging technologies

PURPOSE: An increasing interest in percutaneous ablation of renal tumors has been caused by the increasing incidence of SRMs, the trend toward minimally invasive nephron-sparing treatments and the rapid development of local ablative technologies. In the era of shared decision making, patient prefere...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Urol
Asıl Yazarlar: Zondervan, P. J., Buijs, M., De Bruin, D. M., van Delden, O. M., Van Lienden, K. P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2018
Konular:
Topic Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424924/
https://ncbi.nlm.nih.gov/pubmed/30448873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00345-018-2546-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller